Article Details
Retrieved on: 2022-06-24 08:06:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The London-based company uses a combination of synthetic biology, automation in the laboratory, and AI to develop antibody therapies.
Article found on: techhq.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here